Skip Nav Destination
Targeting TfR1 with the ch128.1/IgG1 Antibody Inhibits EBV-driven Lymphomagenesis in Immunosuppressed Mice Bearing EBV+ Human Primary B-cells
Mol Cancer Ther (2021) 20 (9): 1592–1602.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Guofei Feng
- Yasushi Arima
- Kaoru Midorikawa
- Hatasu Kobayashi
- Shinji Oikawa
- Weilin Zhao
- Zhe Zhang
- Kazuhiko Takeuchi
- Mariko Murata
Cancer Cell International (2023) 23 (1)
Efficacy of Antibodies Targeting TfR1 in Xenograft Mouse Models of AIDS-Related Non-Hodgkin Lymphoma
- Tracy R. Daniels-Wells
- Pierre V. Candelaria
- Emiko Kranz
- Jing Wen
- Lan Wang
- Masakazu Kamata
- Juan C. Almagro
- Otoniel Martínez-Maza
- Manuel L. Penichet
Cancers (2023) 15 (6): 1816.
- Qianqian Guo
- Liwen Li
- Shanshan Hou
- Ziqiao Yuan
- Chenhui Li
- Wenzhou Zhang
- Lufeng Zheng
- Xiaoman Li
Frontiers in Oncology (2021) 11